LEADER 02145nam  2200625Ia 450 
001 9910783138603321
005 20230617033017.0
010   $a0-309-16593-8
010   $a1-280-17612-1
010   $a9786610176120
010   $a0-309-53233-7
035   $a(CKB)1000000000017857
035   $a(OCoLC)57743668
035   $a(CaPaEBR)ebrary10071396
035   $a(SSID)ssj0000241434
035   $a(PQKBManifestationID)11199799
035   $a(PQKBTitleCode)TC0000241434
035   $a(PQKBWorkID)10268078
035   $a(PQKB)10423081
035   $a(MiAaPQ)EBC3377369
035   $a(Au-PeEL)EBL3377369
035   $a(CaPaEBR)ebr10071396
035   $a(CaONFJC)MIL17612
035   $a(OCoLC)923269800
035   $a(EXLCZ)991000000000017857
100   $a20040730d2004      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aSaving lives, buying time$b[electronic resource] $eeconomics of malaria drugs in an age of resistance /$fCommittee on the Economics of Antimalarial Drugs, Board on Global Health ; Kenneth J. Arrow, Claire Panosian, and Hellen Gelband, editors
210   $aWashington, D.C. $cNational Academies Press$dc2004
215   $a1 online resource (384 p.)
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-09218-3 
320   $aIncludes bibliographical references and index.
606   $aAntimalarials$xEconomic aspects
606   $aPharmaceutical policy
606   $aDrug resistance in microorganisms
615  0$aAntimalarials$xEconomic aspects.
615  0$aPharmaceutical policy.
615  0$aDrug resistance in microorganisms.
676   $a616.9/362061
701   $aArrow$b Kenneth Joseph$f1921-$044429
701   $aPanosian$b Claire$01488932
701   $aGelband$b Hellen$01485113
712 02$aInstitute of Medicine (U.S.)$bCommittee on the Economics of Antimalarial Drugs.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910783138603321
996   $aSaving lives, buying time$93795002
997   $aUNINA